Sandra Finley

Nov 022017
 

https://wellnessandequality.com/2016/06/20/how-much-money-do-pediatricians-really-make-from-vaccines/

 

If you want to be sure your pediatrician has your child’s best interest, this is mandatory reading. Pediatricians around the country have begun refusing to accept families who opt out of some or all vaccines. Thanks to a tip sent to Wellness & Equality by a reader, now we know why.

When my friend’s child suffered a life-threatening reaction to a vaccine a week after her first birthday, my friend assumed her pediatrician would write her a medical exemption from future vaccines. Shortly after receiving a routine set of vaccines, the happy, vibrant one-year-old spiked a 106 degree fever, began having seizures, and was hospitalized. When the unexplained “illness” passed after a week in the hospital, the little girl had lost her ability to walk. My friend describes how her daughter, who had learned to walk several months earlier at 9 months, suddenly “stumbled around like a drunk person” for weeks following the vaccines. My friend met with a team of pediatricians, neurologists, and naturopathic doctors, and they agreed: Her daughter had suffered a brain injury caused by a reaction to one of the vaccines. Hoping the injury would be temporary and that she might recover and ease her brain inflammation if they could help her small body quickly eliminate the vaccine additives that caused the reaction, my friend’s daughter underwent an intensive detoxification program overseen by a nutritionalist. Slowly, her daughter relearned to walk.

My friend is a practicing attorney who graduated from a Top 10 college. The evidence was overwhelming that her daughter’s reaction had been caused by vaccines, she told me.

But a few months later, when she took her daughter back into the pediatrician for a visit, he wanted to vaccinate her daughter again. She was baffled. Why?

After a reader sent us a link to a PDF file of Blue Cross Blue Shield’s Physician Incentive Program available online, Wellness & Equality learned that insurance companies pay pediatricians massive bonuses based on the percentage of children who are fully vaccinated by age 2. 

BCBS_ProviderIncentiveProgram.png

So how much money do doctors really make from vaccines? The average American pediatrician has 1546 patients, though some pediatricians see many more. The vast majority of those patients are very young, perhaps because children transition to a family physician or stop visiting the doctor at all as they grow up. As they table above explains, Blue Cross Blue Shield pays pediatricians $400 per fully vaccinated child. If your pediatrician has just 100 fully-vaccinated patients turning 2 this year, that’s $40,000. Yes, Blue Cross Blue Shield pays your doctor a $40,000 bonus for fully vaccinating 100 patients under the age of 2. If your doctor manages to fully vaccinate 200 patients, that bonus jumps to $80,000. 

But here’s the catch: Under Blue Cross Blue Shield’s rules, pediatricians lose the whole bonus unless at least 63% of patients are fully vaccinated, and that includes the flu vaccine. So it’s not just $400 on your child’s head–it could be the whole bonus. To your doctor, your decision to vaccinate your child might be worth $40,000, or much more, depending on the size of his or her practice.

If your pediatrician recommends that your child under the age of 2 receive the flu vaccine–even though the flu vaccine has never been studied in very young children and evidence suggests that the flu vaccine actually weakens a person’s immune system over the long term –ask yourself:  Is my doctor more concerned with selling me vaccines to keep my child healthy or to send his child to private school?

Sources:

The Physician Alliance Blue Cross Blue Shield Incentive Program [Please read our update below to find out how you can access the pamphlet.] 

Update 4/30/2017: After Wellness & Equality published this article, Blue Cross Blue Shield locked online access to their incentive program and then removed the page altogether. Clearly this incentive program was never intended to be public knowledge and created a bit of PR issue for them. Fortunately, another website managed to save the entire BCBS incentive program booklet and has published it in entirety online… You can read it here:  Blue Cross Blue Shield Physician Incentive Program

Getting A Flu Shot Every Year? More May Not Be Better

Distribution of Pediatric Practice: Size, Age, Sex 

Nov 022017
 

Three short paragraphs:

QUESTION 1:  HOW LONG DOES IT TAKE FOR A NEW BORN’S LIVER TO MATURE?

ANSWER:   up to 2 years after birth

https://www.ncbi.nlm.nih.gov/pubmed/15001122

U.S. National Library of Medicine

2003-10-08

Hepatic function and physiology in the newborn.

Abstract

The liver develops from progenitor cells into a well-differentiated organ in which bile secretion can be observed by 12 weeks’ gestation. Full maturity takes up to two years after birth to be achieved, and involves the normal expression of signalling pathways such as that responsible for the JAG1 genes (aberrations occur in Alagille’s syndrome), amino acid transport and insulin growth factors. At birth, hepatocytes are already specialized and have two surfaces: the sinusoidal side receives and absorbs a mixture of oxygenated blood and nutrients from the portal vein; the other surface delivers bile and other products of conjugation and metabolism (including drugs) to the canalicular network which joins up to the bile ductules. There is a rapid induction of functions such as transamination, glutamyl transferase, synthesis of coagulation factors, bile production and transport as soon as the umbilical supply is interrupted. Anatomical specialization can be observed across the hepatic acinus which has three distinct zones. Zone 1 borders the portal tracts (also known as periportal hepatocytes) and is noted for hepatocyte regeneration, bile duct proliferation and gluconeogenesis. Zone 3 borders the central vein and is associated with detoxification (e.g. paracetamol), aerobic metabolism, glycolysis and hydrolysis and zone 2 is an area of mixed function between the two zones. Preterm infants are at special risk of hepatic decompensation because their immaturity results in a delay in achieving normal detoxifying and synthetic function. Hypoxia and sepsis are also frequent and serious causes of liver dysfunction in neonates. Stem cell research has produced many answers to the questions about liver development and regeneration, and genetic studies including studies of susceptibility genes may yield further insights. The possibility that fatty liver (increasingly recognized as non-alcoholic steatohepatitis or NASH) may have roots in the neonatal period is a concept which may have important long-term implications.

PMID:
15001122
DOI:
10.1016/S1084-2756(03)00066-6
= = = = = = = = = = = =  = = = = = = = = = =

QUESTION 2:  WHAT ARE THE CONSEQUENCES OF A DAMAGED LIVER?

ANSWER: Know a bit about the function of the liver and you’ll grasp the significance of damaging it

from  http://www.sciencedirect.com/science/article/pii/S1534580710000559

(Skip the too-technical parts.)

The liver is the largest gland in the body exhibiting both endocrine and exocrine properties. Endocrine functions include the secretion of several hormones such as Insulin-like growth factors, Angiotensinogen, and Thrombopoietin, while the major exocrine secretion is in the form of bile.

The liver is also essential for glycogen storage, drug detoxification, control of metabolism, regulation of cholesterol synthesis and transport, urea metabolism, and secretion of an extensive array of plasma proteins including Albumin and Apolipoproteins.

Since the liver is such an important regulator of normal physiological processes, liver disease, such as hepatic fibrosis, cirrhosis and hepatitis, and hepatocellular carcinoma, results in high rates of morbidity and mortality, so much so that liver disease is the fourth leading cause of death among middle-aged adults in the United States.

The high economical and health burden resulting from liver disease has prompted a call to increase understanding of the basic developmental mechanisms that control liver cell differentiation and function (Action Plan for Liver Disease Research: http://www2.niddk.nih.gov/).

= = = = = = = = = = = =  = = = = = = = = = =

QUESTION 3:  WHY DO THE AMERICANS ADMINISTER THE HEP B VACCINATION SHORTLY AFTER BIRTH?

ANSWER:  You decide.   Personally,  I have a large problem with the idea that you would inject a newborn with toxins when the liver is still in its infancy,

far from being fully developed.

(Hepatitus B is a sexually transmitted disease, also transmitted through needle exchange, or when body fluids from an infected person come into contact with another.  If mothers are drug users they would normally be tested for Hep B prior to the birth of their at-risk baby. (Hep B is like HIV.)

 

From the Centre for Disease Control,   https://www.cdc.gov/vaccines/parents/diseases/child/hepb.html

Doctors recommend that your child get 3 doses of the hepatitis B shot for best protection. Ask your doctor when your child should get the next shot. Typically, children get one dose at each of the following ages:

  • Shortly after birth
  • 1 through 2 months
  • 6 through 18 months

Your child may get a 4th dose depending on the brand of vaccines the doctor uses.

– – – – – – – – –

We are dealing with Big Pharma,  transnationals.  What they get in one jurisdiction, they get in another.   Americans are fighting hard for CHOICE in vaccinations.   Canadians should be doing the same.

Note:

  • families of vaccine-injured children are not challenged by the Vaccine Injury Court if there is, for example, video evidence of a perfectly healthy toddler, who, within a day or few days of vaccination, regresses dramatically, developmentally.   Cause and effect cannot be denied, in the face of the evidence.
  • if newborns are vaccinated,  and injured, there will be no evidence of developmental milestones with which to challenge the vaccinations.  That may be seen as  cynicism,  however,  I’m not saying it’s a reason that newborns are vaccinated.  I am just pointing out a consequence.

Also note:  (U.S.)  a rationale provided for administering multiple vaccinations all at the same time comes down to,  a bird in the hand is worth two in the bush.   You have the subject right there, in your office. Take advantage of the opportunity.  American pediatricians collect healthy incentives if they meet vaccination quotas.   See   How Much Money Do American Pediatricians Really Make From Vaccines?

UPDATE:

2018-02-06 Indian Study Reveals Birth Dose of Hepatitis B Vaccine Unnecessary

Nov 022017
 

Oct 24, good  article below:   EU is on the brink of historic decision . . 

Oct 25,  BRUSSELS (Reuters):  EU delays decision on herbicide glyphosate  …– EU countries failed on Wednesday to vote on a license extension for weedkiller glyphosate, delaying again a decision on the widely used herbicide that critics say could cause cancer.

Glyphosate is found in 60% of UK bread and environmentalists welcome a ban but industry warn of uproar among farmers if herbicide is phased out

Glyphosate is a weedkiller so pervasive that its residues were recently found in 45% of Europe’s topsoil and

in the urine of three quarters of Germans tested. Photograph: Philippe Huguen/AFP/Getty Images

 

A pivotal EU vote this week could revoke the licence for the most widely used herbicide in human history, with fateful consequences for global agriculture and its regulation.

Glyphosate is a weedkiller so pervasive that its residues were recently found in 45% of Europe’s topsoil  – and in the urine of three quarters of Germans tested, at five times the legal limit for drinking water.

Since 1974, almost enough of the enzyme-blocking herbicide has been sprayed to cover every cultivable acre of the planet. Its residues have been found in biscuits, crackers, crisps, breakfast cereals and in 60% of breads sold in the UK.

But environmentalists claim that glyphosate is so non-selective that it can even kill large trees and is destructive to wild and semi-natural habitats, and to biodiversity.

The CEO of the Sustainable Food Trust, Patrick Holden, has said that a ban “could be the beginning of the end of herbicide use in agriculture as we know it, leading to a new chapter of innovation and diversity”.

But industry officials warn of farmers in open revolt, environmental degradation and crops rotting in the fields if glyphosate is banned.

Alarm at glyphosate’s ubiquity has grown since a 2015 study by the World Health Organisation’s IARC cancer agency found that it was  “probably carcinogenic to humans”. More than a million people have petitioned Brussels for a moratorium.

On Tuesday, MEPs will vote on a ban of the chemical by 2020 in a signal to the EU’s deadlocked expert committee, which is due to vote on a new lease the next day.

Anca Paduraru, an EC spokeswoman, said that a decision was needed before 15 December or “for sure the European commission will be taken to court by Monsanto and other industry and agricultural trade representatives for failing to act. We have received letters from Monsanto and others saying this.”

France is resisting a new 10-year licence. Spain is in favour. Germany is in coalition talks and likely to abstain. The UK would normally push for a new lease of the licence but is less engaged due to Brexit. There may not be a qualified majority for any outcome.

A mooted French phase-out of glyphosate was “not realistic”, Paduraru said, although a shorter authorisation might be possible.

Several famers’ associations have threatened lawsuits if the weedkiller is not given a new licence, while the NFU has warned has warned it would entirely “change the way we farm”.

Some research indicates that the surfactants mixed with glyphosate in Monsanto’s Roundup may increase the pesticide’s toxicity by a factor of up to 100. Photograph: Stephanie Lecocq/EPA

Glyphosate is now so widely used in Europe that any ban would have radical consequences. Most herbicides sold in the UK are glyphosate-based and it is integral to the GM industry. The broad spectrum weedkiller makes up a quarter of global herbicide sales. It is mostly used on maize, cotton, soya bean, oilseed and sugar beet crops genetically engineered to resist it.

Industry voices say that the no-tillage system encouraged by glyphosate reduces soil emissions and protects against more environmentally damaging alternative herbicides. Its desiccant qualities are highly convenient for farmers.

A spokesman for the European Crop Protection Agency said: “The longer a crop remains in the ground to dry, the more chance there is that it is exposed to rain and wind and rots.”

Scott Partridge, Monsanto’s VP for corporate strategy, forecast “uproar in the agricultural community” and “a whole host of detrimental effects to crops in the fields” if glyphosate were phased out.

“You would see increased costs for farming and decreased productivity, increased greenhouse gas emissions, loss of topsoil, loss of moisture,” he said. “There would be some significant reaction by farmers through Europe. They would be very upset that a very effective and safe tool had been taken out of their hands.”

Renewal, though, would stoke fears among environmentalists of another decade of increasing toxic chemical use, threatening environmental safety, entrenched regulatory capture and public health. Monsanto insists Roundup is safe to use and points to various studies by the US Environmental Protection Agency (EPA) and other national agencies that have deemed the product safe.

In a Brussels hotel room, Teri McCall, in her new life as a campaigner, has come to lobby against renewal of the licence as she has no doubt that glyphosate causes cancer. After her late-husband, Jack, contracted non-Hodgkin’s lymphoma (NHL) in 2015 she became one of 500 US plaintiffs suing Monsanto, claiming that exposure to its Roundup brand was responsible – a claim Monsanto denies.

“Jack was a farmer since 1975,” says McCall. “For 40 years he used Roundup to keep the weeds down around his newly planted trees. He must have sprayed thousands of gallons of it. He believed it was safe.”

Jack did not smoke or drink, exercised regularly and had no family history of cancer. After lumps appeared on his neck in July 2015, he was diagnosed with NHL aged 69.

“It was an astonishingly swift illness,” McCall says. “I had no idea I was going to lose him. He just kept getting sicker and sicker.” On Christmas day in 2015, the family turned off his life support machine.

Jack’s six-year-old dog Duke also died from the same type of cancer, McCall says. “He was a beautiful black labrador, the most gorgeous dog. He followed Jack around when he was spraying and was also exposed to a lot of Roundup.”

However, Baskut Tuncak, the OHCHR’s special rapporteur on hazardous substances and wastes, says there are “serious questions” about glyphosate’s carcinogenicity, while its regulation evinces “a conflict of interest between politics and the pesticide industry”.

“The chemical industry’s oligopoly has enormous power,” he said. “The pesticide industry has prevented reforms and has blocked the introduction of restrictions on the use of such products in various countries and globally.”

While the EPA has judged glyphosate safe for public use, its methodology was challenged by several of its own scientific advisers last December. They noted an increased NHL risk of between 27-50% when epidemiological data that the EPA had disregarded was considered, sparking criticism of the agency.

Numerous non-industry studies linking glyphosate exposure to tumour development have been ignored by the EPA and other regulators in favour of secret industry reports, conservationists say.

Glyphosate is also tested by regulators in isolation, even though some research indicates that the surfactants it is mixed with in Roundup may increase its toxicity by a factor of up to 100.

The copy and pasting of Monsanto studies into official reports by the European food safety authority (Efsa) has only added to campaigners’ concerns over revelations in the Monsanto papers, unsealed documents released in the US NHL lawsuit.

On her deathbed, an award-winning EPA scientist, Marion Copley, wrote that the original findings of an EPA glyphosate review in 1983 made it “essentially certain that glyphosate causes cancer”.

The question for many farmers is what could take its place. Glyphosate has reduced the need for more toxic alternative herbicides and also for deep tillage – or ploughing – which can be highly damaging to soil fertility.

But its use has also been associated with an increase in farm size and monoculture systems. Environmentalists say that glyphosate is congruous with continuous arable cropping and an acceleration of the “pesticide treadmill”.

Any benefits from a glyphosate ban would come too late for farmers such as Johnny Bob Barton, another non-smoker diagnosed with NHL after 40 years of manually spraying diluted Roundup, on his family farm.

“We were farming a thousand acres of crops and we’d spray using a hose. By the end of the day, you would be saturated down to your pants, boots and socks,” he said. “I never had a choice to say no to this product. There was no warning. Now as a father I have to live with the fact that I exposed my sons to the same thing.”

Monsanto, though, fiercely defends the safety of its product and points to the findings of several regulatory agencies, which dispute the IARC findings.

Farmers say glyphosate has reduced the need for deep ploughing which can be highly damaging to soil fertility. Photograph: Alamy Stock Photo

“Glyphosate is the safest herbicide that has ever been invented,” Partridge said. “While my heart goes out to those suffering from cancer, there is no medical or scientific evidence whatsoever that links the exposure of glyphosate to cancer.”

A report by Pesticide Action Network last week linked the broad spectrum herbicide to dramatic declines in earthworm populations and damaging soil microbial communities. The paper said its use also destroyed food sources for pollinators, and made crops more vulnerable to pathogens and disease.

Dispensing with it would require “a significant redesign of our farming systems”, according to the sustainable food trust, which supports such a move.

Shallow tilling at soil depths limited to 25cm has been shown to reduce weed density and improve long-term soil quality and biodiversity in some studies. Combined with greater crop diversity and rotation, crop rollers, and the use of green manure to raise nitrogen levels, conservationists say that crop yields, soil fertility and carbon storage could all be kept at levels close to today’s.

One firm hoping to benefit from any glyphosate ban is Weedingtech, whose foam and hot water weed treatment is already being used by half of the UK’s water companies and several glyphosate-free councils, including Glastonbury, Hammersmith and Fulham, Southwark and Lewes.

Leo de Montaignac, the firm’s CEO, says the estimated £940m cost to British farmers of a glyphosate ban should be weighed against the substantially higher cost of litigation and environmental and public health damage which may result from herbicide use.

“Companies like ours are already optimising our technology for use in the agricultural sector and we aim to have a production machine for it available before the end of next year,” De Montaignac says.

“There is a huge amount of scaremongering which says that viable alternatives are not available and it is simply not true.”

Nov 022017
 

By DANNY HAKIM

 

The reputation of Roundup, whose active ingredient is the world’s most widely used weed killer, took a hit on Tuesday when a federal court unsealed documents raising questions about its safety and the research practices of its manufacturer, the chemical giant Monsanto.

Roundup and similar products are used around the world on everything from row crops to home gardens. It is Monsanto’s flagship product, and industry-funded research has long found it to be relatively safe. A case in federal court in San Francisco has challenged that conclusion, building on the findings of an international panel that claimed Roundup’s main ingredient might cause cancer.

The court documents included Monsanto’s internal emails and email traffic between the company and federal regulators. The records suggested that Monsanto had ghostwritten research that was later attributed to academics and indicated that a senior official at the Environmental Protection Agency had worked to quash a review of Roundup’s main ingredient, glyphosate, that was to have been conducted by the United States Department of Health and Human Services.

The documents also revealed that there was some disagreement within the E.P.A. over its own safety assessment.

The files were unsealed by Judge Vince Chhabria, who is presiding over litigation brought by people who claim to have developed non-Hodgkin’s lymphoma as a result of exposure to glyphosate. The litigation was touched off by a determination made nearly two years ago by the International Agency for Research on Cancer, a branch of the World Health Organization, that glyphosate was a probable carcinogen, citing research linking it to non-Hodgkin’s lymphoma.

Court records show that Monsanto was tipped off to the determination by a deputy division director at the E.P.A., Jess Rowland, months beforehand. That led the company to prepare a public relations assault on the finding well in advance of its publication. Monsanto executives, in their internal email traffic, also said Mr. Rowland had promised to beat back an effort by the Department of Health and Human Services to conduct its own review.

Dan Jenkins, a Monsanto executive, said in an email in 2015 that Mr. Rowland, referring to the other agency’s potential review, had told him, “If I can kill this, I should get a medal.” The review never took place. In another email, Mr. Jenkins noted to a colleague that Mr. Rowland was planning to retire and said he “could be useful as we move forward with ongoing glyphosate defense.”

The safety of glyphosate is not settled science. A number of agencies, including the European Food Safety Agency and the E.P.A., have disagreed with the international cancer agency, playing down concerns of a cancer risk, and Monsanto has vigorously defended glyphosate.

But the court records also reveal a level of debate within the E.P.A. The agency’s Office of Research and Development raised some concern about the robustness of an assessment carried out by the agency’s Office of Pesticide Programs, where Mr. Rowland was a senior official at the time, and recommended in December 2015 that it take steps to “strengthen” its “human health assessment.”

In a statement, Monsanto said, “Glyphosate is not a carcinogen.”

It added: “The allegation that glyphosate can cause cancer in humans is inconsistent with decades of comprehensive safety reviews by the leading regulatory authorities around the world. The plaintiffs have submitted isolated documents that are taken out of context.”

The E.P.A. had no immediate comment, and Mr. Rowland could not be reached immediately.

Monsanto also rebutted suggestions that the disclosures highlighted concerns that the academic research it underwrites is compromised. Monsanto frequently cites such research to back up its safety claims on Roundup and pesticides.

In one email unsealed Tuesday, William F. Heydens, a Monsanto executive, told other company officials that they could ghostwrite research on glyphosate by hiring academics to put their names on papers that were actually written by Monsanto. “We would be keeping the cost down by us doing the writing and they would just edit & sign their names so to speak,” Mr. Heydens wrote, citing a previous instance in which he said the company had done this.

Asked about the exchange, Monsanto said in a second statement that its “scientists did not ghostwrite the paper” that was referred to or previous work, adding that a paper that eventually appeared “underwent the journal’s rigorous peer review process before it was published.”

David Kirkland, one of the scientists mentioned in the email, said in an interview, “I would not publish a document that had been written by someone else.” He added, “We had no interaction with Monsanto at all during the process of reviewing the data and writing the papers.”

The disclosures are the latest to raise concerns about the integrity of academic research financed by agrochemical companies. Last year, a review by The New York Times showed how the industry can manipulate academic research or misstate findings. Declarations of interest included in a Monsanto-financed paper on glyphosate that appeared in the journal Critical Reviews in Toxicology said panel members were recruited by a consulting firm. Email traffic made public shows that Monsanto officials discussed and debated scientists who should be considered, and shaped the project.

“I think it’s important that people hold Monsanto accountable when they say one thing and it’s completely contradicted by very frank internal documents,” said Timothy Litzenburg of the Miller Firm, one of the law firms handling the litigation.

The issue of glyphosate’s safety is not a trivial one for Americans. Over the last two decades, Monsanto has genetically re-engineered corn, soybeans and cotton so it is much easier to spray them with the weed killer, and some 220 million pounds of glyphosate were used in 2015 in the United States.

“People should know that there are superb scientists in the world who would disagree with Monsanto and some of the regulatory agencies’ evaluations, and even E.P.A. has disagreement within the agency,” said Robin Greenwald, a lawyer at Weitz & Luxenberg, which is also involved in the litigation. “Even in the E.U., there’s been a lot of disagreement among the countries. It’s not so simple as Monsanto makes it out to be.”

Nov 012017
 

For immediate release

 

NZ joins the trend for countries to say no to ISDS, must hold firm in the TPPA

 

‘Yesterday’s announcement that the new government has heeded widespread concerns and taken investor-state dispute settlement (ISDS) off the table in future trade and investment negotiations is a major step forward’, says University of Auckland law professor Jane Kelsey.

‘New Zealand joins a growing number of countries who have rejected the controversial process whereby foreign investors can enforce special protections against governments in private offshore tribunals and claim huge compensation for new regulations or even court decisions that significantly affect their commercial interests’.

‘The Prime Minister’s stronger language regarding the exclusion of ISDS from the Trans-Pacific Partnership Agreement is also welcome, but leaves too much wriggle-room to claim it has failed to convince others, and proceed with the original deal’, Professor Kelsey warns.

Both Viet Nam and Canada are known to want changes to the investment enforcement rules in the TPPA. There are plenty of precedents and mechanisms available.

The government would also have strong support from the legal community. In 2012 more than a hundred jurists, including senior retired judges from Australia and New Zealand, signed an open letter calling for ISDS to be excluded from the TPPA. (https://tpplegal.wordpress.com/open-letter/)

The main rationale for leaving the TPPA intact has been to make it easy for the US to re-join.

While no one currently thinks that likely, Professor Kelsey points to a deeper irony: ‘if the current US administration did re-engage with TPPA, it would require the ability to exempt itself from ISDS!’

‘In the current renegotiation of NAFTA, the US has proposed that each party should be able to opt out of ISDS altogether. The US Trade Representative Robert Lighthizer told US corporations they should act like all other business and take out risk insurance to protect their commercial interests.’

Professor Kelsey called on the new government to stand firm in excluding ISDS from the Agreement, but points out there are many other aspects that remain problematic, including Labour’s own recognition before the election that the economics of the TPPA did not stack up, and that a broader review of the costs and benefits of the TPPA was necessary.

 

Prof Jane Kelsey

Faculty of Law

The University of Auckland

New Zealand

J.kelsey  AT   auckland.ac.nz

Nov 012017
 

Hart writes:
Glyphosate is not necessarily the subject of a new crusade for me. But I do believe that family and friends should know about it. For their own and the health of their families. There are ways to reduce the risks.

The info about the chemical is particularly important in the EU right now.

The frightening part is the effects of lobbying and corruption that still prevents governments to take necessary actions.   See the short book review  . . .

Book review : “Whitewash: The Story of a Weed Killer, Cancer, and the Corruption of Science”

by Carey Gillam, Island Press, 2017

Cover art

 

A few weeks ago I found myself sitting beside a retired chemical engineer at a reunion of my husband’s age-mates in Germany. I’m not sure what made the engineer decide to unleash decades worth of remorse about what his profession had done in the 1960s and 1970s, but that’s what he did.

He said that he, his company and colleagues around the world had knowingly produced many, many toxic chemicals that wound up in our homes, our foods, our bodies, and made us sick. Others they produced were so poisonous they would kill instantly, and were almost impossible to dispose of safely. Many are still in storage today.

I listened, amazed at his candour and aghast at what he was saying. I had just written a book about a fifty-year-old pulp mill in my home province of Nova Scotia in eastern Canada, and about successive waves of public protest over the dangerous chemicals it used and emitted, polluting air, water, and politics. The book also shows how the powerful pulp industry has shaped forest policies and practises in much of Canada, with its regime of clearcutting, planting of conifer monocultures, and then spraying these plantations with herbicides to kill off hardwoods that would compete with them.

The active ingredient in those herbicides is glyphosate. This is the weed-killer that the giant agrochemical and biotech company Monsanto put on the market in 1974 with the name “Roundup,” and complemented 20 years later with its genetically modified (GM) “Roundup Ready” crops that could be sprayed with the herbicide because they had been engineered to withstand it. Governments seemed convinced the weed-killer was safe; they had permitted its use around the world on fields of crops that we eat every day, and anywhere else that human beings want to wipe out plants that dare to put down roots where they are not wanted — on lawns, golf courses, gardens, parks, and playgrounds.

But glyphosate had long been controversial and I was curious as to what the chemist thought of it.

So I interrupted his Mea culpa about his own chemical sins and asked, “What about glyphosate? Is it safe?”

“It should be banned,” he said, without hesitating. “It’s poison.”

I wanted to ask him many more questions. Why, for example, did he (and many others) think glyphosate was dangerous, when the agro-chemical industry (and many others) argue that it is safe enough to drink and harmless to the environment? And why, if it really was harmful, did government agencies around the world approve it so that it has become the most widely used agro-chemical in human history?

Unfortunately, time ran out and I didn’t get to pose these questions.

Imagine my pleasure, then, when a couple of weeks later I learned there was a new book about glyphosate that might answer my questions. Entitled “Whitewash: The Story of a Weed Killer, Cancer, and the Corruption of Science,” it was written by a veteran journalist, Carey Gillam.

The book does not disappoint. Not only does it answer my initial questions, but it also raises and answers many more, and it does so dispassionately and meticulously. She draws on years of research and investigation, countless scientific studies, court documents, interviews with scientists, farmers and regulators, and her previous experience as a senior reporter with Reuters.

When she first started reporting on agriculture, Gillam — like most citizens in democracies — had a lot of faith in the government agencies whose job it is to protect consumers and ensure the safety of farm products and foods, assuming that they wouldn’t approve herbicides such as Roundup and the GM Roundup Ready seeds that Monsanto produced if they posed any risks. She even became a “fan” of Monsanto’s chief technology officer, and said she enjoyed her chats with “the affable Brett Begemann” who had risen through the ranks to become Monsanto’s president.

But, as time passed, and her research and reports began to expose doubts about GM crops and glyphosate-based herbicides, she discovered that Monsanto could also be far from affable. The company tried to have her editors take her off the beat and their surrogates engaged in smear campaigns.

Eventually, Gillam left Reuters and joined the non-profit, US Right to Know, with its stated goal of “pursuing truth and transparency in America’s food system.” Her book offers readers 251 pages of compelling evidence that there is an urgent need for just such truth and transparency, that glyphosate poses many risks for human health, farms, crops, soils and the environment, and that Monsanto and the agro-chemical industry have gone to extraordinary lengths and expense to hide these from regulators and the public.

We learn that in the mid-1980s, a decade after Monsanto began promoting glyphosate as the safest herbicide ever, the Environmental Protection Agency (EPA) in the United States classified the chemical as a “possible human carcinogen.” Then, in 1991, after “extensive input” from Monsanto, the EPA did an about-face, deciding there was “evidence of non-carcinogenicity for humans.”

Over the years, study after independent study found that glyphosate was linked with health problems, with cancers such as non-Hodgkin lymphoma, chromosomal damage in blood cells, endocrine disruption, kidney or liver disease, and hormonal changes, among others. The combination of other ingredients with glyphosate in herbicide formulas made it even more dangerous.

Then there were the giant superweeds that were springing up in fields of Roundup Ready crops, which were resistant to glyphosate. To try to get rid of them, farmers were being forced to go back to deep tilling and every greater use of herbicides, both of which were things Monsanto promised its GM seeds and herbicides would reduce.

Researchers also found that the use of glyphosate around conventional and GM crops weakened their root systems, making them more vulnerable to disease and crop failures, such as that which has devastated Florida’s citrus crops. One independent scientist who determined that glyphosate destroys soil health tells Gillam, “When you spray glyphosate on a plant it’s like giving it AIDS.”

Monsanto and the agro-chemical industry pushed back at every step, publicizing its own studies that did not have to go through a peer review, hiring ghost-writers and providing them with messages, engaging industry-friendly scientists to write industry-friendly papers, and attacking genuinely independent scientists who contradicted them, trying to discredit them. As Gillam documents so diligently, this pattern repeated itself over and over and over again, and continues today.

“So where, one might ask, are the regulators?” asks Gillam at one point. A good question that she answers with ,a litany of rock-solid examples of how regulators have failed the public when it comes to glyphosate-based herbicides, be it the Environmental Protection Agency or the Department of Agriculture or the Food and Drug Administration (FDA) in the US. Or the Federal Institute for Risk Assessment and Ministry of Food and Agriculture in Germany. And although she doesn’t focus on the Canadian Food Inspection Agency (CFIA), she does note that it did not require annual testing for glyphosate residues until 2017, after the research branch of the World Health Organization categorized glyphosate as “probably carcinogenic to humans.”

Gillam admits that the story of glyphosate, the sacrificing of public safety for corporate profits for agro-chemical giants and the corporate capture of regulatory agencies, is not a “feel-good story.” This is certainly true. Page after page detailing the perfidy of compliant politicians and scientists, and the silencing of honest researchers within regulatory agencies, can be hard on the soul. It challenges head-on the myths that Monsanto (which the German giant Bayer is trying to take over) and others in the business of profiting from pesticides and GM crops have spread so effectively that their mission is to feed the world, something one senior scientist tells Gillam is “a bunch of garbage.”

At the same time, this book is hard to put down, as fast-paced and full of intrigue as any thriller, and it does offer glimmers of hope. After the World Health Organization labelled glyphosate a probable carcinogen, and despite the backlash from industry, lapdogs in regulatory agencies and even some media, many people believing their cancer came from exposure to glyphosate decided to take Monsanto to court. This brought to light damming documents that reveal still more of the subterfuge that surrounds glyphosate.

One professor emeritus of plant pathology tells her, “Future historians may well look back on our time and write about us … how willing we were to sacrifice our children and jeopardize future generations based on false promises and flawed science just to benefit the bottom line of a commercial enterprise.”

As Gillam notes, some believe that the chemical may turn out to have been worse than its poisonous predecessors — DDT and Agent Orange.

Her work on glyphosate leads her to conclude that “…when powerful corporations control the narrative, the truth often gets lost, and it’s up to journalists to find it and bring it home.”

This is exactly what Carey Gillam has done masterfully in this must-read book.

Oct 312017
 

By Bill Curry

The Liberal government has introduced a second large budget bill that includes a new law establishing Canada’s participation in the Beijing-based Asian Infrastructure Investment Bank.

Bill C-63, Finance Minister Bill Morneau’s second budget bill of the year, enacts a wide range of measures related to his March budget. Like the first budget bill, it is more than 300 pages, repeating a practice that has faced opposition criticism for lacking transparency.

The bill includes a new law called the Asian Infrastructure Investment Bank Agreement Act, which sets the terms for Canada’s relationship with the emerging bank.

Mr. Morneau’s March budget made one reference to the bank, stating that Ottawa would be contributing $256-million over five years to the Asian Infrastructure Investment Bank (AIIB). Yet, the budget bill gives the Finance Minister the authority to transfer up to $375-million (U.S.), which is about $480-million in Canadian dollars. A Finance Department official said the legislation would give Canada the flexibility to buy more bank shares than the current plan of $256-million if desired.

Canada’s decision to join the more than 60 countries participating in the AIIB was announced the same week as the 2017 budget was released. The bank is viewed as China’s counterweight to the U.S.-led World Bank and Japan’s Asian Development Bank. It is also part of China’s One Belt One Road policy of expanding its international influence through infrastructure.

Since the bank’s launch in 2015, it has funded several large infrastructure projects throughout Asia, including a flood management project in Manila, electrical transmission work in India, a highway in Pakistan and a natural gas pipeline in Azerbaijan. The bank, which has more than $100-billion (U.S.) in available capital, received a AAA credit rating from Moody’s Investors Services earlier this year.

Canada’s participation in the AIIB comes as Prime Minister Justin Trudeau has sent clear signals of his desire to expand trade links with China. These efforts coincide with a period of considerable uncertainty regarding the future of Canada’s economic relationship with the United States in light of ongoing talks to renegotiate the North American free-trade agreement.

This week, a state-owned firm, China Communications Construction Co. Ltd., announced that it is buying Canada’s largest publicly traded construction company, Aecon Group Inc.

Mr. Trudeau said on Friday that the transaction will receive a full review under the Investment Canada Act.

Neither the United States nor Japan have joined the AIIB and Canada did not express support under Conservative prime minister Stephen Harper. Canada’s decision to sign on was a concrete sign of Mr. Trudeau’s efforts to forge a deeper relationship with China, where the Prime Minister’s father, former prime minister Pierre Trudeau, is highly regarded for establishing diplomatic relations with the People’s Republic of China in 1970.

Mr. Morneau’s first budget bill, C-44, came within a vote of being blocked in the Senate in late June largely because many senators opposed the fact that it included new legislation creating the $35-billion Canada Infrastructure Bank.

Many senators said the Finance Minister should have introduced the Canada Infrastructure Bank Act as a stand-alone bill, so that it could have received more detailed scrutiny. The Senate chose to hold several hearings specifically on the infrastructure bank aspects of the first budget bill.

NDP MP Nathan Cullen said the government raises suspicions when it places large initiatives inside a budget bill.

“If they’re proud of the policy, if it’s something that they’re wanting Canadians to know about, then don’t bury it in hundreds of pages,” he said. Mr. Cullen noted that Parliament has received little information about Canada’s role in the AIIB and the Trudeau government’s broader plans to strengthen ties with China.

“This is clearly part of the China agenda with Trudeau,” he said. “The challenge with that entire agenda is it’s been low on transparency and high on ambition. I think Canadians are right to raise concerns about what exactly it is that we’re offering to China.”

Daniel Lauzon, a spokesman for the Finance Minister, said Canada’s participation in the AIIB is clearly a budget measure that should be included in a budget bill. He said Canada’s participation in the AIIB “will create jobs here at home and help the middle class around the world.”

Conservative finance critic Pierre Poilievre said the bank forces Canadian taxpayers to shoulder the risk of private projects in other countries.

“If investors want to profit off infrastructure, that is fine. But they, not taxpayers, should take the financial risk,” he said. “The Asian Infrastructure Bank is yet another Liberal handout to the world’s wealthy at taxpayers’ expense. … Investors get the profit and taxpayers get the financial risk of infrastructure megaprojects, many of which are not even in Canada.”

Oct 292017
 

I made a submission to the Government about the Bowser Sewage Treatment Plant (“Opportunity! …).

Reply from the Deputy Minister of Environment received (I have some follow-up to do.):

 

Reference:  311945

October 19, 2017

 

Dear Ms. Finley:

 

On behalf of the Honourable George Heyman, Minister of Environment and Climate Change Strategy, thank you very much for your email of September 13, 2017, regarding the Regional District of Nanaimo’s (RDN’s) proposed sewage treatment system and outfall intended to serve the Bowser Village. I am pleased to have this opportunity to respond.

 

I appreciate the time you have taken to share some of your ideas with us. Your comments regarding alternative treatment options, source water protection and cumulative effects are valuable and have been provided to Ministry staff on the South Authorization Team in the Environmental Protection Division for consideration during adjudication of any future application for this project.

 

At this time, the Ministry has not yet received a formal application for a proposed system to service the Bowser Village Centre so I am unable to respond with specific comments on the RDN proposal in relation to your concerns. However, I would like to assure you that my ministry and our new government take the protection of our air, land and water resources seriously and will ensure that the environment and human health is at the forefront of our decision-making.

 

Prior to submitting an application for a municipal wastewater discharge, the Ministry requires meaningful consultation with members of the community and First Nations. The results of these efforts are then presented as part of the submission to the Ministry. Once received by the Ministry, an application for a municipal effluent discharge is assessed according to the requirements identified in the Municipal Wastewater Regulation, and in accordance with the principles in the RDN’s Liquid Waste Management Plan. This includes the preparation of an environmental impact assessment. You can learn more about the regulatory requirements and authorization process on our website at http://www2.gov.bc.ca/gov/content/environment/waste-management/sewage/municipal-wastewater-regulation.

 

Planning and public consultation regarding the types and locations of proposed wastewater treatment systems, including the outfall, rest with the local government. I understand that residents in the area to be serviced by the proposed sewerage system supported the project in a recent petition, allowing the RDN to proceed to the next phase of detailed design and consultation with the broader community. I also note that the RDN website contains significant information on the proposed facility, with community engagement details, recent updates and direct contact information to the appropriate RDN staff working on this project. I encourage you to visit their website at http://www.rdn.bc.ca/cms.asp?wpID=3609, and participate in the ongoing consultation process.

 

Thank you again for taking the time to express your concerns and for sharing your personal experiences.

 

Sincerely,

 

 

Mark Zacharias

Deputy Minister

 

cc         A.J. Downie, Director, Authorizations – South, Environmental Protection Division, Ministry of Environment and Climate Change Strategy

Oct 292017
 

Data shows companies made much higher payments to developing countries in 2016 than to Canadian, provincial governments

Canada taxes its oil and gas companies at a fraction of the rate they are taxed abroad, including by countries ranked among the world’s most corrupt, according to an analysis of public data by the Guardian.

The low rate that oil companies pay in Canada represents billions of dollars in potential revenue lost, which an industry expert who looked at the data says is a worrying sign that the country may be “a kind of tax haven for our own companies.”

The countries where oil companies paid higher rates of taxes, royalties and fees per barrel in 2016 include Nigeria, Indonesia, Ivory Coast and the UK.

“I think it will come as a surprise to most Canadians, including a lot of politicians, that Canada is giving oil companies a cut-rate deal relative to other countries,” said Keith Stewart, an energy analyst with Greenpeace.

Companies like Chevron Canada paid almost three times as much to Nigeria and almost seven times as much to Indonesia as it did to Canadian, provincial and municipal governments.

Chevron used to run its Nigeria and Indonesia projects out of the U.S., but after allegations that they evaded billions in taxes, their operations were moved to Canada.

According to data collected by the Guardian, Suncor also paid six times more taxes to the UK, and Canadian Natural Resources Limited (CNRL) paid almost four times more to Ivory Coast.

 

(Please go to the URL, to see the bar graph –  – https://www.theguardian.com/environment/true-north/2017/oct/26/revealed-oil-giants-pay-billions-less-tax-in-canada-than-abroad)

Oil company payments to governments in Canada and abroad
Payment per barrel in Canadian dollars, 2016
Chevron Canada
Canada
Nigeria
Indonesia

Suncor Energy Inc
Canada
UK

CNRL
Canada
Ivory Coast
Guardian graphic | Source: Natural Resources Canada

The revelations emerge as tax reforms proposed by the Liberal government to curb the use of loopholes by wealthy Canadians continue to be hotly debated and opposed by business lobby groups.

Even with the low rates, the Canadian Association of Petroleum Producers has been lobbying the federal government for more tax breaks to improve their “competitiveness.”

The Guardian used a new extractive sector database launched in June, 2017, after a law passed by Stephen Harper required oil, gas, and mining companies in Canada to disclose for the first time payments they make to governments around the world. The Guardian compared payment figures for 2016 to oil production levels.

The result of a global push for “publish-what-you-pay” corporate transparency, the Canadian law was billed as a way to empower citizens in developing countries to ensure more tax revenue is collected for much-needed social programs. While it was supported by Canada’s mining industry, oil companies fought against full disclosures.

“Publish-what-you-pay was set up to help fight corruption in the developing world, but ironically this data reveals that it’s Canada who is getting the short end of the stick when it comes to the public’s share of oil revenue,” said Stewart. “The Trudeau government should be demanding that oil companies pay at least as much tax here as they do abroad, and use that money to fund a transition to green energy.”

According to resource governance expert and UBC geography professor Philippe Le Billon, neoliberal policies in Canada and across OECD countries have resulted in lower taxes and royalties for companies.

“Companies in Canada will point to the jobs they are creating rather than acknowledge they could be sharing more of their profits, which mostly goes to shareholders who are not even in the country,” he said. “In key jurisdictions like Alberta, this has come about after decades of rule by Conservatives who are very cozy with oil interests. The numbers reveal a poor tradeoff: high emissions for not much revenue. It’s long-past time for Canada to follow a model like Norway’s, which captures far more revenue from oil production.”

While royalty rates in Newfoundland are the highest in Canada, in Alberta they have fallen from a 40 per cent high during the 1970s to less than four per cent, and a complex system of exemptions ensures companies often pay even less. The NDP government in Alberta backed away from a pledge to hike them.

Le Billon said the tax gap between Canada and developing countries has also been influenced by lower prices for Canadian crude and higher production costs.

“[Production in Africa] generated positive segmented earnings, therefore generating higher associated payments to the local Governments. In contrast, last year our Canadian conventional operations were generating operating losses, hence lower payment levels to Canadian governments,” a spokesperson for CNRL said. They reported losses of $204 million last year but have made $1.07 billion in profits in their latest quarter in 2017.

Chevron Canada did not directly address the discrepancy in tax rates, but a spokesperson said its reporting to the extractive sector database “are one of many important roles that Chevron Canada and our industry peers play as we produce safe and reliable energy and partner with communities and first nations [sic].” They reported losses of $497 million in 2016 after making $4.6 billion in 2015.

Suncor, which reported profits of $1.9 billion in 2016, did not return a request for comment. All three companies pay massive dividends to shareholders every year.

Natural Resources Canada referred questions to the Finance Ministry, which did not respond to questions.

Justin Trudeau’s Liberal government and the provinces also continue to give $3.3 billion in yearly subsidies to fossil fuel producers in the country, despite having pledged to phase them out.

Sep 182017
 

(Note:  links are good, even in they appear not to be.)

B.C. Premier Horgan and the NDP government are planning to pass Ban Big Money legislation.

From the beginning, this has truly been a grassroots movement. When we launched the Ban Big Money campaign, the media ignored us and politicians told us it couldn’t be done. But tens of thousands of everyday British Columbians came together to say “enough is enough.” And now, here we stand, on the edge of something great.

Last week we asked for your input into what you thought the gold standard should be for Ban Big Money laws.

2,179 of you took the time to make your voices heard, and we can’t thank you enough. Here are the results.

Already our volunteer teams are out knocking on their MLAs’ doors and phoning their offices, presenting them with the results of our survey. They are making sure elected officials know, after decades of living in the no-holds-barred Wild West, British Columbians won’t settle for anything less than the best.

Please stay vigilant this week — watch the announcements and look at the details. We want to make sure this law meets our standards. If it doesn’t, contact your MLA and let them know their job isn’t finished yet. And if it truly is ideal, celebrate.

Let’s drive this home,

Lisa

 

 

PLEASE DONATE

 

https://dogwoodbc.ca/donate-generaldynamic/